Three-dimensional bioprinting of thick vascularized tissues
The advancement of tissue and, ultimately, organ engineering requires the ability to pattern human tissues composed of cells, extracellular matrix, and vasculature with controlled microenvironments that can be sustained over prolonged time periods. To date, bioprinting methods have yielded thin tiss...
Saved in:
Published in | Proceedings of the National Academy of Sciences - PNAS Vol. 113; no. 12; pp. 3179 - 3184 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
United States
National Academy of Sciences
22.03.2016
National Acad Sciences |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The advancement of tissue and, ultimately, organ engineering requires the ability to pattern human tissues composed of cells, extracellular matrix, and vasculature with controlled microenvironments that can be sustained over prolonged time periods. To date, bioprinting methods have yielded thin tissues that only survive for short durations. To improve their physiological relevance, we report a method for bioprinting 3D cell-laden, vascularized tissues that exceed 1 cm in thickness and can be perfused on chip for long time periods (>6 wk). Specifically, we integrate parenchyma, stroma, and endothelium into a single thick tissue by coprinting multiple inks composed of human mesenchymal stem cells (hMSCs) and human neonatal dermal fibroblasts (hNDFs) within a customized extracellular matrix alongside embedded vasculature, which is subsequently lined with human umbilical vein endothelial cells (HUVECs). These thick vascularized tissues are actively perfused with growth factors to differentiate hMSCs toward an osteogenic lineage in situ. This longitudinal study of emergent biological phenomena in complex microenvironments represents a foundational step in human tissue generation. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Edited by Kristi S. Anseth, Howard Hughes Medical Institute, University of Colorado Boulder, Boulder, CO, and approved February 2, 2016 (received for review October 28, 2015) 1D.B.K., K.A.H., and M.A.S.-S. contributed equally to this work. Author contributions: D.B.K., K.A.H., M.A.S.-S., and J.A.L. designed research; D.B.K., K.A.H., and M.A.S.-S. performed research; D.B.K., K.A.H., M.A.S.-S., and J.A.L. analyzed data; and D.B.K. and J.A.L. wrote the paper. |
ISSN: | 0027-8424 1091-6490 |
DOI: | 10.1073/pnas.1521342113 |